The import of ephedrines to Canada is expected to decrease steadily from 2024 to 2028, beginning at 1.5144 Million USD in 2024 and declining to 1.383 Million USD by 2028. Compared to 2023, the projected 2024 value represents the first decrease as previous data is not available. The year-on-year variation shows a consistent negative trend, with a minor decrease each year.
- 2024 to 2025: Approximately -2.24% decline
- 2025 to 2026: Approximately -2.23% decline
- 2026 to 2027: Approximately -2.24% decline
- 2027 to 2028: Approximately -2.26% decline
The five-year compound annual growth rate (CAGR) over the projected period reflects a gradual decline, consistent with the yearly decreases.
Future trends to watch for include potential regulatory changes impacting ephedrine imports, shifts in demand due to alternative medical treatments, and broader economic conditions affecting international trade. Monitoring these factors will be crucial for understanding import dynamics beyond 2028.
